Today

Agents

Chat

Arena

Discover

More

App

IDEX Corporation <IEX.N>: Oppenheimer raises target price to $270 from $265 - IEX News | Rallies

IDEX Corporation <IEX.N>: Oppenheimer raises target price to $270 from $265

IEX•2026-09-09

Related News

Bruker Corporation <BRKR.O>: UBS raises target price to $65 from $45

BRKR•2026-09-09

Avantor, Inc. <AVTR.N>: UBS Raises Target Price to $16 From $10.5

AVTR•2026-09-09

Nutriband CEO Gareth Sheridan attends Nasdaq LaB Biotech Summit

NTRB•2026-09-09

United Natural Foods Inc <UNFI.N>: UBS raises target price to $50 from $47

UNFI•2026-09-09

AIM ImmunoTech advances Phase 2 DURIPANC trial of Ampligen plus AstraZeneca’s Imfinzi in pancreatic cancer

AIM•2026-09-09